Paper697346
In vitro studies with Sch 21420 and Sch 22591: activity in comparison with six other aminoglycosides and synergy with penicillin against enterococci.
Sanders CC and 2 others. Antimicrob Agents Chemother, 1978. Cited by 27 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. In vitro studies with Sch 21420 and Sch 22591: activity in comparison with six other aminoglycosides and synergy with penicillin against enterococci. Papers, record 697346. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/697346
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- In vitro studies with Sch 21420 and Sch 22591: activity in comparison with six other aminoglycosides and synergy with penicillin against enterococci.
- PubMed
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Anti-Bacterial Agents | Major topic |
| Enterobacteriaceae | Major topic |
| Gentamicins | Major topic |
| Penicillin G | Major topic |
| Sisomicin | Major topic |
| Aminoglycosides | |
| Drug Synergism | |
| Microbial Sensitivity Tests |
Source PubMed
References6
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 14,047,217 | NEISSERIA GONORRHOEAE. I. VIRULENCE GENETICALLY LINKED TO CLONAL VARIATION. | J Bacteriol | 1963 | https://conductscience.org/library/papers/14047217 | PubMed |
| 2 | 242,509 | Synergy of penicillin-netilmicin combinations against enterococci including strains highly resistant to streptomycin or kanamycin. | Antimicrob Agents Chemother | 1977 | https://conductscience.org/library/papers/242509 | PubMed |
| 3 | 626,490 | Chemotherapeutic evaluation of 5-episisomicin (Sch 22591), a new semisynthetic aminoglycoside. | Antimicrob Agents Chemother | 1978 | https://conductscience.org/library/papers/626490 | PubMed |
| 4 | 1,008,541 | Biological activity of netilmicin, a broad-spectrum semisynthetic aminoglycoside antibiotic. | Antimicrob Agents Chemother | 1976 | https://conductscience.org/library/papers/1008541 | PubMed |
| 5 | 4,209,522 | Activity of BB-K8 (amikacin) against clinical isolates resistant to one or more aminoglycoside antibiotics. | Antimicrob Agents Chemother | 1974 | https://conductscience.org/library/papers/4209522 | PubMed |
| 6 | 4,468,277 | Mutamicins; biosynthetically created new sisomicin analogues. | J Antibiot (Tokyo) | 1974 | https://conductscience.org/library/papers/4468277 | PubMed |
Cited by9
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 27 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 8,851,618 | Temporal variation in nephrotoxicity of low doses of isepamicin in rats. | Antimicrob Agents Chemother | 1996 | https://conductscience.org/library/papers/8851618 | PubMed |
| 7,447,420 | Interpretive standards for disk susceptibility tests with Sch 21420 and amikacin. | Antimicrob Agents Chemother | 1980 | https://conductscience.org/library/papers/7447420 | PubMed |
| 7,447,410 | Comparison of in vitro activity of Sch 21420, a gentamicin B derivative, with those of amikacin, gentamicin, netilmicin, sisomicin, and tobramycin. | Antimicrob Agents Chemother | 1980 | https://conductscience.org/library/papers/7447410 | PubMed |
| 7,283,421 | In vitro studies with Win 42122-2: comparison with gentamicin, netilmicin, and amikacin. | Antimicrob Agents Chemother | 1981 | https://conductscience.org/library/papers/7283421 | PubMed |
| 6,376,062 | Sisomicin, netilmicin and dibekacin. A review of their antibacterial activity and therapeutic use. | Drugs | 1984 | https://conductscience.org/library/papers/6376062 | PubMed |
| 3,583,277 | Netilmicin: new approach to treating gonorrhoea. | Genitourin Med | 1987 | https://conductscience.org/library/papers/3583277 | PubMed |
| 2,689,137 | Netilmicin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use. | Drugs | 1989 | https://conductscience.org/library/papers/2689137 | PubMed |
| 742,870 | Comparison of 5-episisomicin (Sch 22591), gentamicin, sisomicin, and tobramycin in treatment of experimental Pseudomonas infections in mice. | Antimicrob Agents Chemother | 1978 | https://conductscience.org/library/papers/742870 | PubMed |
| 518,078 | Comparative nephrotoxicity of SCH 21420 and amikacin in rats. | Antimicrob Agents Chemother | 1979 | https://conductscience.org/library/papers/518078 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/697346
GET https://conductscience.org/api/papers/v1/697346/authors